EP Patent

EP0842660A1 — Composition for treating condyloma acuminata

Assigned to Cancer Hospital and Institute of CAMS and PUMC · Expires 1998-05-20 · 28y expired

What this patent protects

The invention describes a pharmaceutical composition containing a tea (Camellia sinensis) extract containing catechins (more particularly (-)-epigallocatechin gallate) in the form of a 2-20% by weight ointment or a 50-500 mg tea catechin suppository and its use in the treatment o…

USPTO Abstract

The invention describes a pharmaceutical composition containing a tea (Camellia sinensis) extract containing catechins (more particularly (-)-epigallocatechin gallate) in the form of a 2-20% by weight ointment or a 50-500 mg tea catechin suppository and its use in the treatment of condyloma acuminata (genital warts) caused by human papilloma virus.

Drugs covered by this patent

Patent Metadata

Patent number
EP0842660A1
Jurisdiction
EP
Classification
Expires
1998-05-20
Drug substance claim
No
Drug product claim
No
Assignee
Cancer Hospital and Institute of CAMS and PUMC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.